Toxic Aβ-fibrinogen Alliance Linked to Alzheimer's Onset
Researchers identified a toxic alliance between amyloid-beta and fibrinogen that may explain how Alzheimer's disease begins. The two proteins together create stubborn clots that damage blood vessels and spark inflammatio
Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer's disease begins. The two proteins together create stubborn clots that damage blood vessels and spark inflammation in the brain.
These effects appear even at very low concentrations and disrupt the blood-brain barrier, paving the way for neurodegeneration. The findings highlight a potential new therapeutic target for early intervention.
The study suggests that this interaction may serve as an early biomarker or mechanism for disease progression. Understanding how these proteins interact could inform strategies to prevent vascular damage associated with cognitive decline.
Researchers caution that further validation is needed before clinical application. This work remains in the realm of laboratory research and does not constitute medical advice.